The DaBlaCa-13 Study: Short-term, Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in Non–muscle-invasive Bladder Cancer—A Randomised Controlled Trial

Controlled Trial ◽

Invasive Bladder Cancer ◽

Short Term ◽

Muscle Invasive ◽

Randomised Controlled ◽

Intravesical Instillations

Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial

The Lancet Oncology ◽

10.1016/s1470-2045(11)70190-5 ◽

2011 ◽

Vol 12 (9) ◽

pp. 871-879 ◽

Cited By ~ 87

Author(s):

Savino M Di Stasi ◽

Marco Valenti ◽

Cristian Verri ◽

Emanuele Liberati ◽

Arcangelo Giurioli ◽

...

Keyword(s):

Bladder Cancer ◽

Transurethral Resection ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

Muscle Invasive ◽

Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non–muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial

European Urology ◽

10.1016/j.eururo.2018.09.005 ◽

2019 ◽

Vol 75 (1) ◽

pp. 63-71 ◽

Cited By ~ 28

Author(s):

Wei Shen Tan ◽

Anesh Panchal ◽

Laura Buckley ◽

Adam J. Devall ◽

Laurence S. Loubière ◽

...

Keyword(s):

Bladder Cancer ◽

Controlled Trial ◽

Phase Iii ◽

Invasive Bladder Cancer ◽

Open Label ◽

Muscle Invasive ◽

Re: Radiofrequency-Induced Thermo-Chemotherapy Effect versus a Second Course of bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non-Muscle-Invasive Bladder Cancer following Induction or Maintenance bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-Label, Randomised Controlled Trial

The Journal of Urology ◽

10.1097/ju.0000000000000676 ◽

2020 ◽

Vol 203 (3) ◽

pp. 461-462

Author(s):

Sam S. Chang

Keyword(s):

Bladder Cancer ◽

Controlled Trial ◽

Phase Iii ◽

Invasive Bladder Cancer ◽

Open Label ◽

Muscle Invasive ◽

A Phase II, Open Label, Multicenter Randomised Controlled Trial Comparing Hyperthermia Plus Mitomycin To Mitomycin Alone, In Patients with Intermediate Risk Non-Muscle Invasive Bladder Cancer

http://isrctn.org/> ◽

10.1186/isrctn23639415 ◽

2014 ◽

Cited By ~ 1

Author(s):

Shriram Velamuri

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

Intermediate Risk ◽

Open Label ◽

Muscle Invasive ◽

Re: Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial

European Urology ◽

10.1016/j.eururo.2019.01.030 ◽

2019 ◽

Vol 75 (5) ◽

pp. 879-880

Author(s):

Piotr Radziszewski ◽

Sławomir Poletajew

Keyword(s):

Bladder Cancer ◽

Controlled Trial ◽

Phase Iii ◽

Invasive Bladder Cancer ◽

Open Label ◽

Muscle Invasive ◽

Neoadjuvant cisplatin,methotrexate,and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial

The Lancet ◽

10.1016/s0140-6736(99)02292-8 ◽

1999 ◽

Vol 354 (9178) ◽

pp. 533-540 ◽

Cited By ~ 359

Keyword(s):

Bladder Cancer ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

Muscle Invasive ◽

Reply to Claudia Signorini and Massimo Maffezzini’s Letter to the Editor re: Maria S. Lindgren, Peter Bue, Nessn Azawi, et al. The DaBlaCa-13 Study: Short-term, Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in Non–muscle-invasive Bladder Cancer—A Randomized Controlled Trial. Eur Urol 2020;78:856–62

European Urology ◽

10.1016/j.eururo.2021.02.001 ◽

2021 ◽

Author(s):

Maria S. Lindgren ◽

Jørgen B. Jensen

Keyword(s):

Bladder Cancer ◽

Randomized Controlled Trial ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

Short Term ◽

Randomized Controlled ◽

Letter To The Editor ◽

Muscle Invasive ◽

Intravesical Instillations

Re: Electromotive Instillation of Mitomycin Immediately Before Transurethral Resection for Patients With Primary Urothelial Non-Muscle Invasive Bladder Cancer: A Randomised Controlled Trial

The Journal of Urology ◽

10.1016/j.juro.2012.02.2519 ◽

2012 ◽

Vol 187 (6) ◽

pp. 2023-2024

Author(s):

David P. Wood

Keyword(s):

Bladder Cancer ◽

Transurethral Resection ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

Muscle Invasive ◽

Re: Maria S. Lindgren, Peter Bue, Nessn Azawi, et al. The DaBlaCa-13 Study: Short-term, Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in Non–muscle-invasive Bladder Cancer—A Randomized Controlled Trial. Eur Urol 2020;78:856–62

European Urology ◽

10.1016/j.eururo.2021.01.034 ◽

2021 ◽

Vol 79 (5) ◽

pp. e135-e136

Author(s):

Claudia Signorini ◽

Massimo Maffezzini

Keyword(s):

Bladder Cancer ◽

Randomized Controlled Trial ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

Short Term ◽

Randomized Controlled ◽

Muscle Invasive ◽

Intravesical Instillations

Re: Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C versus bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer

The Journal of Urology ◽

10.1016/j.juro.2018.06.043 ◽

2018 ◽

Vol 200 (4) ◽

pp. 696-697

Author(s):

Sam S. Chang

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Muscle Invasive ◽